Effects of aldosterone on insulin sensitivity and secretion

Steroids

Volumn 91, Issue , 2014, Pages 54-60

  Luther, James M ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aldosterone; Diabetes; Hypertension; Insulin sensitivity Insulin secretion; Mineralocorticoid receptor

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ALDOSTERONE; CYTOKINE; GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN; INSULIN RECEPTOR; MINERALOCORTICOID; MINERALOCORTICOID RECEPTOR; POTASSIUM; REACTIVE OXYGEN METABOLITE;

ADIPOCYTE; ALDOSTERONE RELEASE; ARTICLE; CYTOSKELETON; DIABETES MELLITUS; FATTY LIVER; GENE REARRANGEMENT; GENE TRANSLOCATION; GLUCONEOGENESIS; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; HORMONE ACTION; HUMAN; HYPERALDOSTERONISM; HYPOKALEMIA; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRACELLULAR SIGNALING; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET; PATHOPHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; SKELETAL MUSCLE; VASCULAR DISEASE; VITAMIN SUPPLEMENTATION; BIOLOGICAL MODEL; CLINICAL TRIAL (TOPIC); PATHOLOGY; SECRETION (PROCESS);

ALDOSTERONE; CLINICAL TRIALS AS TOPIC; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN; INSULIN RESISTANCE; MODELS, BIOLOGICAL;

EID: 84910074179     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2014.08.016     Document Type: Review

References (118)

1. J.W. Conn Hypertension, the potassium ion and impaired carbohydrate tolerance N Engl J Med 273 1965 1135 1143
2. J.W. Conn, R.F. Knopf, and R.M. Nesbit Clinical characteristics of primary aldosteronism from an analysis of 145 cases Am J Surg 107 1964 159 172
3. American Diabetes A: Diagnosis and classification of diabetes mellitus. Diabetes Care 2013;36 Suppl 1:S67-74.
4. H.M. Jin, D.C. Zhou, H.F. Gu, Q.Y. Qiao, S.K. Fu, X.L. Liu, and Y. Pan Antioxidant N-acetylcysteine protects pancreatic beta-cells against aldosterone-induced oxidative stress and apoptosis in female db/db mice and insulin-producing MIN6 cells Endocrinology 154 2013 4068 4077
5. J.M. Luther, P. Luo, M.T. Kreger, M. Brissova, C. Dai, T.T. Whitfield, H.S. Kim, D.H. Wasserman, A.C. Powers, and N.J. Brown Aldosterone decreases glucose-stimulated insulin secretion in vivo in mice and in murine islets Diabetologia 54 2011 2152 2163
6. J. Pierluissi, F.O. Navas, and S.J. Ashcroft Effect of adrenal steroids on insulin release from cultured rat islets of Langerhans Diabetologia 29 1986 119 121
7. J.R. Sowers, A. Whaley-Connell, and M. Epstein Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension Ann Intern Med 150 2009 776 783
8. M.L. Tuck, J. Sowers, L. Dornfeld, G. Kledzik, and M. Maxwell The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients N Engl J Med 304 1981 930 933
9. T.L. Goodfriend, B.M. Egan, and D.E. Kelley Plasma aldosterone, plasma lipoproteins, obesity and insulin resistance in humans Prostaglandins Leukot Essent Fatty Acids 60 1999 401 405
10. R. Bentley-Lewis, G.K. Adler, T. Perlstein, E.W. Seely, P.N. Hopkins, G.H. Williams, and R. Garg Body mass index predicts aldosterone production in normotensive adults on a high-salt diet J Clin Endocrinol Metab 92 2007 4472 4475
11. M. Ehrhart-Bornstein, V. Lamounier-Zepter, A. Schraven, J. Langenbach, H.S. Willenberg, A. Barthel, H. Hauner, S.M. McCann, W.A. Scherbaum, and S.R. Bornstein Human adipocytes secrete mineralocorticoid-releasing factors Proc Natl Acad Sci USA 100 2003 14211 14216
12. T.L. Goodfriend, D.L. Ball, B.M. Egan, W.B. Campbell, and K. Nithipatikom Epoxy-keto derivative of linoleic acid stimulates aldosterone secretion Hypertension 43 2004 358 363
13. M. Nagase, S. Yoshida, S. Shibata, T. Nagase, T. Gotoda, K. Ando, and T. Fujita Enhanced aldosterone signaling in the early nephropathy of rats with metabolic syndrome: possible contribution of fat-derived factors J Am Soc Nephrol 17 2006 3438 3446
14. D.T. Investigators, J. Bosch, S. Yusuf, H.C. Gerstein, J. Pogue, P. Sheridan, G. Dagenais, R. Diaz, A. Avezum, F. Lanas, J. Probstfield, G. Fodor, and R.R. Holman Effect of ramipril on the incidence of diabetes N Engl J Med 355 2006 1551 1562
15. Group NS, McMurray JJ, Holman RR, Haffner SM, Bethel MA, Holzhauer B, Hua TA, Belenkov Y, Boolell M, Buse JB, Buckley BM, Chacra AR, Chiang FT, Charbonnel B, Chow CC, Davies MJ, Deedwania P, Diem P, Einhorn D, Fonseca V, Fulcher GR, Gaciong Z, Gaztambide S, Giles T, Horton E, Ilkova H, Jenssen T, Kahn SE, Krum H, Laakso M, Leiter LA, Levitt NS, Mareev V, Martinez F, Masson C, Mazzone T, Meaney E, Nesto R, Pan C, Prager R, Raptis SA, Rutten GE, Sandstroem H, Schaper F, Scheen A, Schmitz O, Sinay I, Soska V, Stender S, Tamas G, Tognoni G, Tuomilehto J, Villamil AS, Vozar J, Califf RM: Effect of valsartan on the incidence of diabetes and cardiovascular events. N Engl J Med 2010;362:1477-1490.
16. C. Weyer, C. Bogardus, D.M. Mott, and R.E. Pratley The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus J Clin Invest 104 1999 787 794
17. DeFronzo RA: Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 1988;37:667-687.
18. B. Ahren, and G. Pacini Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess beta cell function in clinical studies Eur J Endocrinol 150 2004 97 104
19. S.E. Kahn, R.L. Prigeon, D.K. McCulloch, E.J. Boyko, R.N. Bergman, M.W. Schwartz, J.L. Neifing, W.K. Ward, J.C. Beard, and J.P. Palmer Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects Diabetes 42 1993 1663 1672
20. A. Gastaldelli, E. Ferrannini, Y. Miyazaki, M. Matsuda, and R.A. Defronzo Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study Diabetologia 47 2004 31 39
21. R.N. Bergman, L.S. Phillips, and C. Cobelli Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose J Clin Invest 68 1981 1456 1467
22. C.J. Rhodes Type 2 diabetes-a matter of beta-cell life and death? Science 307 2005 380 384
23. S.E. Kahn, R.L. Hull, and K.M. Utzschneider Mechanisms linking obesity to insulin resistance and type 2 diabetes Nature 444 2006 840 846
24. R.L. Pande, T.S. Perlstein, J.A. Beckman, and M.A. Creager Association of insulin resistance and inflammation with peripheral arterial disease: the National Health and Nutrition Examination Survey, 1999 to 2004 Circulation 118 2008 33 41
25. F. Abbasi, B.W. Brown Jr., C. Lamendola, T. McLaughlin, and G.M. Reaven Relationship between obesity, insulin resistance, and coronary heart disease risk J Am Coll Cardiol 40 2002 937 943
26. M. Pyorala, H. Miettinen, P. Halonen, M. Laakso, and K. Pyorala Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study Arterioscler Thromb Vasc Biol 20 2000 538 544
27. R.S. Vasan, J.C. Evans, M.G. Larson, P.W. Wilson, J.B. Meigs, N. Rifai, E.J. Benjamin, and D. Levy Serum aldosterone and the incidence of hypertension in nonhypertensive persons N Engl J Med 351 2004 33 41
28. Calhoun DA: Is there an unrecognized epidemic of primary aldosteronism? Pro. Hypertension 2007;50:447-453; discussion 447-453.
29. N.M. Bellili, L. Foucan, F. Fumeron, K. Mohammedi, F. Travert, R. Roussel, B. Balkau, J. Tichet, and M. Marre Associations of the -344 T>C and the 3097 G>A polymorphisms of CYP11B2 gene with hypertension, type 2 diabetes, and metabolic syndrome in a French population Am J Hypertens 23 2010 660 667
30. K. Ranade, K.D. Wu, N. Risch, M. Olivier, D. Pei, C.F. Hsiao, L.M. Chuang, L.T. Ho, E. Jorgenson, R. Pesich, Y.D. Chen, V. Dzau, A. Lin, R.A. Olshen, D. Curb, D.R. Cox, and D. Botstein Genetic variation in aldosterone synthase predicts plasma glucose levels Proc Natl Acad Sci U S A 98 2001 13219 13224
31. P. Russo, F. Lauria, M. Loguercio, G. Barba, J. Arnout, and F.P. Cappuccio -344C/T Variant in the promoter of the aldosterone synthase gene (CYP11B2) is associated with metabolic syndrome in men Am J Hypertens 20 2007 218 222
32. L. Pojoga, S. Gautier, H. Blanc, T.T. Guyene, O. Poirier, F. Cambien, and A. Benetos Genetic determination of plasma aldosterone levels in essential hypertension Am J Hypertens 11 1998 856 860
33. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
34. T.M. Wallace, J.C. Levy, and D.R. Matthews Use and abuse of HOMA modeling Diab Care 27 2004 1487 1495
35. E.M. Freel, I.K. Tsorlalis, J.D. Lewsey, R. Latini, A.P. Maggioni, S. Solomon, B. Pitt, J.M. Connell, and J.J. McMurray Aldosterone status associated with insulin resistance in patients with heart failure-data from the ALOFT study Heart 95 2009 1920 1924
36. T.L. Goodfriend, D.E. Kelley, B.H. Goodpaster, and S.J. Winters Visceral obesity and insulin resistance are associated with plasma aldosterone levels in women Obes Res 7 1999 355 362
37. Y. Huan, S. Deloach, S.W. Keith, T.L. Goodfriend, and B. Falkner Aldosterone and aldosterone: renin ratio associations with insulin resistance and blood pressure in African Americans J Am Soc Hypertens 6 2012 56 65
38. S. Kidambi, J.M. Kotchen, C.E. Grim, H. Raff, J. Mao, R.J. Singh, and T.A. Kotchen Association of adrenal steroids with hypertension and the metabolic syndrome in blacks Hypertension 49 2007 704 711
39. Kidambi S, Kotchen JM, Krishnaswami S, Grim CE, Kotchen TA: Hypertension, insulin resistance, and aldosterone: sex-specific relationships. J Clin Hypertens (Greenwich) 2009;11:130-137.
40. G. Colussi, C. Catena, R. Lapenna, E. Nadalini, A. Chiuch, and L.A. Sechi Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients Diabet Care 30 2007 2349 2354
41. G. Giacchetti, V. Ronconi, F. Turchi, L. Agostinelli, F. Mantero, S. Rilli, and M. Boscaro Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study J Hypertens 25 2007 177 186
42. G. Sindelka, J. Widimsky, T. Haas, M. Prazny, J. Hilgertova, and J. Skrha Insulin action in primary hyperaldosteronism before and after surgical or pharmacological treatment Exp Clin Endocr Diab 108 2000 21 25
43. J. Widimsky Jr., G. Sindelka, T. Haas, M. Prazny, J. Hilgertova, and J. Skrha Impaired insulin action in primary hyperaldosteronism Physiol Res 49 2000 241 244
44. C. Catena, R. Lapenna, S. Baroselli, E. Nadalini, G. Colussi, M. Novello, G. Favret, A. Melis, A. Cavarape, and L.A. Sechi Insulin sensitivity in patients with primary aldosteronism: a follow-up study J Clin Endocrinol Metab 91 2006 3457 3463
45. M. Ishimori, N. Takeda, S. Okumura, T. Murai, H. Inouye, and K. Yasuda Increased insulin sensitivity in patients with aldosterone producing adenoma Clin Endocrinol (Oxf) 41 1994 433 438
46. J. Widimsky Jr., B. Strauch, G. Sindelka, and J. Skrha Can primary hyperaldosteronism be considered as a specific form of diabetes mellitus? Physiol Res 50 2001 603 607
47. E. Fischer, C. Adolf, A. Pallauf, C. Then, M. Bidlingmaier, F. Beuschlein, J. Seissler, and M. Reincke Aldosterone excess impairs first phase insulin secretion in primary aldosteronism J Clin Endocrinol Metab 98 2013 2513 2520
48. Kumagai E, Adachi H, Jacobs DR, Jr., Hirai Y, Enomoto M, Fukami A, Otsuka M, Kumagae S, Nanjo Y, Yoshikawa K, Esaki E, Yokoi K, Ogata K, Kasahara A, Tsukagawa E, Ohbu-Murayama K, Imaizumi T: Plasma aldosterone levels and development of insulin resistance: prospective study in a general population. Hypertension 2011;58:1043-1048.
49. B. Strauch, J. Widimsky, G. Sindelka, and J. Skrha Does the treatment of primary hyperaldosteronism influence glucose tolerance? Physiol Res 52 2003 503 506
50. V.T. Samuel, and G.I. Shulman Mechanisms for insulin resistance: common threads and missing links Cell 148 2012 852 871
51. E.J. Barrett, E.M. Eggleston, A.C. Inyard, H. Wang, G. Li, W. Chai, and Z. Liu The vascular actions of insulin control its delivery to muscle and regulate the rate-limiting step in skeletal muscle insulin action Diabetologia 52 2009 752 764
52. D. Leto, and A.R. Saltiel Regulation of glucose transport by insulin: traffic control of GLUT4 Nat Rev Mol Cell Biol 13 2012 383 396
53. J.S. Bogan Regulation of glucose transporter translocation in health and diabetes Annu Rev Biochem 81 2012 507 532
54. T.T. Chiu, T.E. Jensen, L. Sylow, E.A. Richter, and A. Klip Rac1 signalling towards GLUT4/glucose uptake in skeletal muscle Cell Signal 23 2011 1546 1554
55. K.J. Mather, H.O. Steinberg, and A.D. Baron Insulin resistance in the vasculature J Clin Invest 123 2013 1003 1004
56. A.D. Baron, H.O. Steinberg, H. Chaker, R. Leaming, A. Johnson, and G. Brechtel Insulin-mediated skeletal muscle vasodilation contributes to both insulin sensitivity and responsiveness in lean humans J Clin Invest 96 1995 786 792
57. A.D. Baron The coupling of glucose metabolism and perfusion in human skeletal muscle. The potential role of endothelium-derived nitric oxide Diabetes 45 Suppl 1 1996 S105 S109
58. A. McCurley, P.W. Pires, S.B. Bender, M. Aronovitz, M.J. Zhao, D. Metzger, P. Chambon, M.A. Hill, A.M. Dorrance, M.E. Mendelsohn, and I.Z. Jaffe Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors Nat Med 18 2012 1429 1433
59. D. Pruthi, A. McCurley, M. Aronovitz, C. Galayda, S.A. Karumanchi, and I.Z. Jaffe Aldosterone promotes vascular remodeling by direct effects on smooth muscle cell mineralocorticoid receptors Arterioscler Thromb Vasc Biol 34 2014 355 364
60. J.M. Luther, P. Luo, Z. Wang, S.E. Cohen, H.S. Kim, A.B. Fogo, and N.J. Brown Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury Kidney Int 82 2012 643 651
61. N. Hernandez, S.H. Torres, H.J. Finol, A. Sosa, and M. Cierco Capillary and muscle fiber type changes in DOCA-salt hypertensive rats Anat Rec 246 1996 208 216
62. M. Losada, S.H. Torres, N. Hernandez, M. Lippo, and A. Sosa Muscle arteriolar and venular reactivity in two models of hypertensive rats Microvasc Res 69 2005 142 148
63. H. Hitomi, H. Kiyomoto, A. Nishiyama, T. Hara, K. Moriwaki, K. Kaifu, G. Ihara, Y. Fujita, T. Ugawa, and M. Kohno Aldosterone suppresses insulin signaling via the downregulation of insulin receptor substrate-1 in vascular smooth muscle cells Hypertension 50 2007 750 755
64. S.B. Bender, A.P. McGraw, I.Z. Jaffe, and J.R. Sowers Mineralocorticoid receptor-mediated vascular insulin resistance: an early contributor to diabetes-related vascular disease? Diabetes 62 2013 313 319
65. S.J. Sherajee, Y. Fujita, K. Rafiq, D. Nakano, H. Mori, T. Masaki, T. Hara, M. Kohno, A. Nishiyama, and H. Hitomi Aldosterone induces vascular insulin resistance by increasing insulin-like growth factor-1 receptor and hybrid receptor Arterioscler Thromb Vasc Biol 32 2012 257 263
66. T. Cascella, Y. Radhakrishnan, L.A. Maile, W.H. Busby Jr., K. Gollahon, A. Colao, and D.R. Clemmons Aldosterone enhances IGF-I-mediated signaling and biological function in vascular smooth muscle cells Endocrinology 151 2010 5851 5864
67. G. Galmiche, A. Pizard, A. Gueret, S. El Moghrabi, A. Ouvrard-Pascaud, S. Berger, P. Challande, I.Z. Jaffe, C. Labat, P. Lacolley, and F. Jaisser Smooth muscle cell mineralocorticoid receptors are mandatory for aldosterone-salt to induce vascular stiffness Hypertension 63 2014 520 526
68. J.J. Dupont, M.A. Hill, S.B. Bender, F. Jaisser, and I.Z. Jaffe Aldosterone and vascular mineralocorticoid receptors: regulators of ion channels beyond the kidney Hypertension 63 2014 632 637
69. D.H. Wasserman Four grams of glucose Am J Physiol Endocrinol Metab 296 2009 E11 E21
70. L. Kang, L. Lantier, A. Kennedy, J.S. Bonner, W.H. Mayes, D.P. Bracy, L.H. Bookbinder, A.H. Hasty, C.B. Thompson, and D.H. Wasserman Hyaluronan accumulates with high-fat feeding and contributes to insulin resistance Diabetes 62 2013 1888 1896
71. R. Rocha, C.L. Martin-Berger, P. Yang, R. Scherrer, J. Delyani, and E. McMahon Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart Endocrinology 143 2002 4828 4836
72. J. Selvaraj, T. Muthusamy, C. Srinivasan, and K. Balasubramanian Impact of excess aldosterone on glucose homeostasis in adult male rat Clin Chim Acta 407 2009 51 57
73. J. Selvaraj, S. Sathish, C. Mayilvanan, and K. Balasubramanian Excess aldosterone-induced changes in insulin signaling molecules and glucose oxidation in gastrocnemius muscle of adult male rat Mol Cell Biochem 372 2013 113 126
74. S.J. Sherajee, K. Rafiq, D. Nakano, H. Mori, H. Kobara, H. Hitomi, Y. Fujisawa, H. Kobori, T. Masaki, and A. Nishiyama Aldosterone aggravates glucose intolerance induced by high fructose Eur J Pharmacol 720 2013 63 68
75. G. Lastra, A. Whaley-Connell, C. Manrique, J. Habibi, A.A. Gutweiler, L. Appesh, M.R. Hayden, Y. Wei, C. Ferrario, and J.R. Sowers Low-dose spironolactone reduces reactive oxygen species generation and improves insulin-stimulated glucose transport in skeletal muscle in the TG(mRen2)27 rat Am J Physiol Endocrinol Metab 295 2008 E110 E116
76. E.A. Alexander, and N.G. Levinsky An extrarenal mechanism of potassium adaptation J Clin Invest 47 1968 740 748
77. S. Adler An extrarenal action of aldosterone on mammalian skeletal muscle Am J Physiol 218 1970 616 621
78. S. Goldfarb, M. Cox, I. Singer, and M. Goldberg Acute hyperkalemia induced by hyperglycemia: hormonal mechanisms Ann Intern Med 84 1976 426 432
79. K.L. Zierler, and D. Rabinowitz Effect of very small concentrations of insulin on forearm metabolism. Persistence of its action on potassium and free fatty acids without its effect on glucose J Clin Invest 43 1964 950 962
80. K.L. Zierler Effect of insulin on potassium efflux from rat muscle in the presence and absence of glucose Am J Physiol 198 1960 1066 1070
81. T. Wada, S. Ohshima, E. Fujisawa, D. Koya, H. Tsuneki, and T. Sasaoka Aldosterone inhibits insulin-induced glucose uptake by degradation of insulin receptor substrate (IRS) 1 and IRS2 via a reactive oxygen species-mediated pathway in 3T3-L1 adipocytes Endocrinology 150 2009 1662 1669
82. P. Li, X.N. Zhang, C.M. Pan, F. Sun, D.L. Zhu, H.D. Song, and M.D. Chen Aldosterone perturbs adiponectin and PAI-1 expression and secretion in 3T3-L1 adipocytes Horm Metab Res 43 2011 464 469
83. M. Caprio, B. Feve, A. Claes, S. Viengchareun, M. Lombes, and M.C. Zennaro Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis FASEB J 21 2007 2185 2194
84. A.T. Turer, and P.E. Scherer Adiponectin: mechanistic insights and clinical implications Diabetologia 55 2012 2319 2326
85. C. Guo, V. Ricchiuti, B.Q. Lian, T.M. Yao, P. Coutinho, J.R. Romero, J. Li, G.H. Williams, and G.K. Adler Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines Circulation 117 2008 2253 2261
86. A. Hirata, N. Maeda, A. Hiuge, T. Hibuse, K. Fujita, T. Okada, S. Kihara, T. Funahashi, and I. Shimomura Blockade of mineralocorticoid receptor reverses adipocyte dysfunction and insulin resistance in obese mice Cardiovasc Res 84 2009 164 172
87. T.A. Williams, S. Monticone, R. Urbanet, C. Bertello, G. Giraudo, R. Vettor, F. Fallo, F. Veglio, and P. Mulatero Genes implicated in insulin resistance are down-regulated in primary aldosteronism patients Mol Cell Endocrinol 355 2012 162 168
88. F. Fallo, P. Della Mea, N. Sonino, C. Bertello, M. Ermani, R. Vettor, F. Veglio, and P. Mulatero Adiponectin and insulin sensitivity in primary aldosteronism Am J Hypertens 20 2007 855 861
89. R. Urbanet, C. Pilon, A. Calcagno, A. Peschechera, E.L. Hubert, G. Giacchetti, C. Gomez-Sanchez, P. Mulatero, M. Toffanin, N. Sonino, M.C. Zennaro, F. Giorgino, R. Vettor, and F. Fallo Analysis of insulin sensitivity in adipose tissue of patients with primary aldosteronism J Clin Endocrinol Metab 95 2010 4037 4042
90. P. Luo, A. Dematteo, Z. Wang, L. Zhu, A. Wang, H.S. Kim, A. Pozzi, J.M. Stafford, and J.M. Luther Aldosterone deficiency prevents high-fat-feeding-induced hyperglycaemia and adipocyte dysfunction in mice Diabetologia 56 2013 901 910
91. X. Liang, M.B. Butterworth, K.W. Peters, and R.A. Frizzell AS160 modulates aldosterone-stimulated epithelial sodium channel forward trafficking Mol Biol Cell 21 2010 2024 2033
92. K.M. Geraghty, S. Chen, J.E. Harthill, A.F. Ibrahim, R. Toth, N.A. Morrice, F. Vandermoere, G.B. Moorhead, D.G. Hardie, and C. MacKintosh Regulation of multisite phosphorylation and 14-3-3 binding of AS160 in response to IGF-1, EGF. PMA and AICAR. Biochem J 407 2007 231 241
93. S. Chen, S. Synowsky, M. Tinti, and C. MacKintosh The capture of phosphoproteins by 14-3-3 proteins mediates actions of insulin Trends Endocrinol Metab 22 2011 429 436
94. A. Zaini, P. Pearce, and J.W. Funder High-affinity aldosterone binding in rat liver-a re-evaluation Clin Exp Pharmacol Physiol 14 1987 39 45
95. Reul JM, Pearce PT, Funder JW, Krozowski ZS: Type I and type II corticosteroid receptor gene expression in the rat: effect of adrenalectomy and dexamethasone administration. Mol Endocrinol 1989;3:1674-1680.
96. R. Yamashita, T. Kikuchi, Y. Mori, K. Aoki, Y. Kaburagi, K. Yasuda, and H. Sekihara Aldosterone stimulates gene expression of hepatic gluconeogenic enzymes through the glucocorticoid receptor in a manner independent of the protein kinase B cascade Endocr J 51 2004 243 251
97. G. Liu, M. Grifman, B. Keily, J.E. Chatterton, F.W. Staal, and Q.X. Li Mineralocorticoid receptor is involved in the regulation of genes responsible for hepatic glucose production Biochem Biophys Res Commun 342 2006 1291 1296
98. T. Wada, Y. Miyashita, M. Sasaki, Y. Aruga, Y. Nakamura, Y. Ishii, M. Sasahara, K. Kanasaki, M. Kitada, D. Koya, H. Shimano, H. Tsuneki, and T. Sasaoka Eplerenone ameliorates the phenotypes of metabolic syndrome with NASH in liver-specific SREBP-1c Tg mice fed high-fat and high-fructose diet Am J Physiol Endocrinol Metab 305 2013 E1415 E1425
99. T. Wada, H. Kenmochi, Y. Miyashita, M. Sasaki, M. Ojima, M. Sasahara, D. Koya, H. Tsuneki, and T. Sasaoka Spironolactone improves glucose and lipid metabolism by ameliorating hepatic steatosis and inflammation and suppressing enhanced gluconeogenesis induced by high-fat and high-fructose diet Endocrinology 151 2010 2040 2049
100. R. Noguchi, H. Yoshiji, Y. Ikenaka, K. Kaji, Y. Shirai, Y. Aihara, M. Yamazaki, T. Namisaki, M. Kitade, J. Yoshii, K. Yanase, H. Kawaratani, T. Tsujimoto, and H. Fukui Selective aldosterone blocker ameliorates the progression of non-alcoholic steatohepatitis in rats Int J Mol Med 26 2010 407 413
101. A. Gamliel-Lazarovich, A. Raz-Pasteur, R. Coleman, and S. Keidar The effects of aldosterone on diet-induced fatty liver formation in male C57BL/6 mice: comparison of adrenalectomy and mineralocorticoid receptor blocker Eur J Gastroenterol Hepatol 25 2013 1086 1092
102. F. Fallo, A. Dalla Pozza, M. Tecchio, F. Tona, N. Sonino, M. Ermani, C. Catena, C. Bertello, P. Mulatero, N. Sabato, B. Fabris, and L.A. Sechi Nonalcoholic fatty liver disease in primary aldosteronism: a pilot study Am J Hypertens 23 2010 2 5
103. J.F. Ndisang, and A. Jadhav The heme oxygenase system attenuates pancreatic lesions and improves insulin sensitivity and glucose metabolism in deoxycorticosterone acetate hypertension Am J Physiol Regul Integr Comp Physiol 298 2010 R211 R223
104. J.C. Chuang, J.Y. Cha, J.C. Garmey, R.G. Mirmira, and J.J. Repa Research resource: nuclear hormone receptor expression in the endocrine pancreas Mol Endocrinol 22 2008 2353 2363
105. R. Gros, Q. Ding, L.A. Sklar, E.E. Prossnitz, J.B. Arterburn, J. Chorazyczewski, and R.D. Feldman GPR30 expression is required for the mineralocorticoid receptor-independent rapid vascular effects of aldosterone Hypertension 57 2011 442 451
106. M. Barton Position paper: the membrane estrogen receptor GPER-Clues and questions Steroids 77 2012 935 942
107. W.W. Batenburg, P.M. Jansen, and A.J. van den Bogaerdt AH JD: Angiotensin II-aldosterone interaction in human coronary microarteries involves GPR30, EGFR, and endothelial NO synthase Cardiovasc Res 94 2012 136 143
108. C. Jacovetti, A. Abderrahmani, G. Parnaud, J.C. Jonas, M.L. Peyot, M. Cornu, R. Laybutt, E. Meugnier, S. Rome, B. Thorens, M. Prentki, D. Bosco, and R. Regazzi MicroRNAs contribute to compensatory beta cell expansion during pregnancy and obesity J Clin Invest 122 2012 3541 3551
109. G. Sharma, C. Hu, J.L. Brigman, G. Zhu, H.J. Hathaway, and E.R. Prossnitz GPER deficiency in male mice results in insulin resistance, dyslipidemia, and a proinflammatory state Endocrinology 154 2013 4136 4145
110. G. Sharma, and E.R. Prossnitz Mechanisms of estradiol-induced insulin secretion by the G protein-coupled estrogen receptor GPR30/GPER in pancreatic beta-cells Endocrinology 152 2011 3030 3039
111. Wendler A, Wehling M: Is GPR30 the membrane aldosterone receptor postulated 20 years ago? Hypertension 2011;57:e16; author reply e17.
112. L.M. Mosso, C.A. Carvajal, A. Maiz, E.H. Ortiz, C.R. Castillo, R.A. Artigas, and C.E. Fardella A possible association between primary aldosteronism and a lower beta-cell function J Hypertens 25 2007 2125 2130
113. K. Shimamoto, M. Shiiki, T. Ise, Y. Miyazaki, K. Higashiura, M. Fukuoka, A. Hirata, A. Masuda, M. Nakagawa, and O. Iimura Does insulin resistance participate in an impaired glucose tolerance in primary aldosteronism? J Hum Hypertens 8 1994 755 759
114. N.J. van der Zijl, C.C. Moors, G.H. Goossens, E.E. Blaak, and M. Diamant Does interference with the renin-angiotensin system protect against diabetes? Evidence and mechanisms Diab Obes Metab 14 2012 586 595
115. J.R. Sowers, L. Raij, I. Jialal, B.M. Egan, E.O. Ofili, R. Samuel, D.H. Zappe, D. Purkayastha, and P.C. Deedwania Angiotensin receptor blocker/diuretic combination preserves insulin responses in obese hypertensives J Hypertens 28 2010 1761 1769
116. N.J. van der Zijl, C.C. Moors, G.H. Goossens, M.M. Hermans, E.E. Blaak, and M. Diamant Valsartan improves {beta}-cell function and insulin sensitivity in subjects with impaired glucose metabolism: a randomized controlled trial Diab Care 34 2011 845 851
117. J.M. Luther, J.V. Gainer, L.J. Murphey, C. Yu, D.E. Vaughan, J.D. Morrow, and N.J. Brown Angiotensin II induces interleukin-6 in humans through a mineralocorticoid receptor-dependent mechanism Hypertension 48 2006 1050 1057
118. K. Swaminathan, J. Davies, J. George, N.S. Rajendra, A.D. Morris, and A.D. Struthers Spironolactone for poorly controlled hypertension in type 2 diabetes: conflicting effects on blood pressure, endothelial function, glycaemic control and hormonal profiles Diabetologia 51 2008 762 768